SharesGrow 7-Criteria Score
All 7 criteria scored · valuation-related highlighted on this page
Marks and Spencer Group plc (MAKSF) trades at a trailing P/E of 32.5, forward P/E of 19.9. Trailing earnings yield is 3.08%, forward earnings yield 5.03%. PEG 0.31 (Peter Lynch undervalued ≤1.0).
Criteria proven by this page:
- VALUE (40/100, Partial) — mixed signals — some valuation metrics are favorable while others are stretched.
- Forward P/E 19.9 (down from trailing 32.5) — analysts expect earnings to grow, which would improve the valuation.
- PEG Ratio 0.31 — below 1.0 suggests the stock is undervalued relative to its earnings growth rate (Peter Lynch criterion).
- Trailing Earnings Yield 3.08% — roughly competitive with bond yields (~4.3%), moderate risk-reward. Forward yield improves to 5.03% as earnings recover.
Overall SharesGrow Score: 51/100 with 1/7 criteria passed.
SharesGrow 7-Criteria Score
~
VALUE
40/100
Price-to-Earnings & upside
Proven by this page
✗
HEALTH
33/100
Debt-to-Equity & liquidity
→ Health
Valuation Snapshot — MAKSF
Valuation Multiples
P/E (TTM)32.5
Forward P/E19.9
PEG Ratio0.31
Forward PEG0.31
P/B Ratio0.00
P/S Ratio0.70
EV/EBITDA0.0
Per Share Data
EPS (TTM)$0.14
Forward EPS (Est.)$0.23
Book Value / Share$0.00
Revenue / Share$6.55
FCF / Share$0.00
Yields & Fair Value
Earnings Yield3.08%
Forward Earnings Yield5.03%
Dividend Yield0.00%
P/E Ratio & Earnings Yield
Earnings Per Share (EPS) History
| Year |
EPS (Diluted) |
Revenue |
Net Income |
Net Margin |
| 2016 |
$0.24 |
$10.56B |
$406.9M |
3.9% |
| 2017 |
$0.07 |
$10.62B |
$117.1M |
1.1% |
| 2018 |
$0.02 |
$10.7B |
$25.7M |
0.2% |
| 2019 |
$0.02 |
$10.38B |
$41.7M |
0.4% |
| 2020 |
$0.01 |
$10.18B |
$23.7M |
0.2% |
| 2021 |
$-0.10 |
$9.16B |
$-198M |
-2.2% |
| 2022 |
$0.15 |
$10.89B |
$306.6M |
2.8% |
| 2023 |
$0.18 |
$11.93B |
$363.4M |
3% |
| 2024 |
$0.21 |
$13.04B |
$431.2M |
3.3% |
| 2025 |
$0.14 |
$13.82B |
$295.7M |
2.1% |
